Pharmaceuticals

Peptide Antibiotics Industry Insights: Market Forecast to 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Peptide Antibiotics Market Expected To Become By 2029 Compared With Its 2025 Level?

The peptide antibiotics market size has experienced robust expansion in recent years. Projections show it will increase from $5.25 billion in 2024 to $5.77 billion in 2025, driven by a compound annual growth rate (CAGR) of 9.8%. This historical growth can be attributed to the discovery and ongoing development of peptide antibiotics, the growing challenge of antibiotic resistance, an increase in the incidence of infectious diseases, advancements in peptide synthesis technologies, and the overall growth of the pharmaceutical industry.

The peptide antibiotics market is projected to experience substantial expansion over the coming years. It is forecast to reach $8.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period stems from factors such as a heightened focus on developing new antibiotics, the rising worldwide occurrence of antibiotic-resistant infections, increased research and development efforts in antimicrobial peptides, and supportive regulatory frameworks for approving novel antibiotics. Key trends expected throughout this period encompass the investigation of natural sources for antimicrobial peptides, the use of peptide antibiotics in animal health, a concentrated effort on peptide engineering to improve effectiveness, the creation of combination peptide antibiotics, and the incorporation of AI and machine learning into the process of discovering peptide antibiotics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Which Major Market Drivers Are Shaping The Future Of The Peptide Antibiotics Market?

The rising occurrence of various infectious diseases is projected to drive the expansion of the peptide antibiotics market. These illnesses are caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. Major factors contributing to the increase in infectious diseases include rapid urbanization, climate change, and a growing risk of disease emergence, which have all heightened the demand for peptide antibiotics. Peptide antibiotics function by physically rupturing cell membranes and providing antibacterial activity. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, dengue cases in the America region had already surpassed seven million by April 2024, which is much higher than the 4.6 million cases reported in all of 2023. Therefore, the increased incidence of infectious diseases is propelling the peptide antibiotics market growth.

How Is The Peptide Antibiotics Market Segmented?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What Trends Are Expected To Drive The Peptide Antibiotics Market?

Strategic collaborations are emerging as a significant development in the peptide antibiotics market. Leading companies within this sector are forming partnerships to broaden their market reach and capitalize on shared resources. For instance, in January 2022, Berkeley Lights, a US-based digital cell biology firm, established a partnership with Aanika Biosciences. Through this collaboration, Aanika intends to utilize Berkeley Lights’ high-throughput, functional screening service to rapidly identify and refine functional antimicrobial peptides (AMPs) effective against hazardous bacteria, particularly those responsible for foodborne disease outbreaks. Furthermore, the Beacon Optofluidic Platform will be employed to pinpoint peptides detrimental to bacteria, facilitating the creation of an innovative antibacterial tag. This tag will subsequently be integrated into Aanika’s bacterial spore-based barcoding technology, aiming to enhance the security of the food supply chain. Aanika Biosciences is a US-based biotechnology company.

Who Are The Key Multinational Companies Dominating The Peptide Antibiotics Market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Peptide Antibiotics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

Browse Through More Reports Similar to the Global Peptide Antibiotics Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nutritional Feed Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Pharmacies And Drug Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795